• 作者：Roy Mano ; M.D.^a ; ¹ ; ^{roymano78@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Emily A. Vertosick ; M.P.H.^b ; Abraham Ari Hakimi ; M.D.^a ; Itay A. Sternberg ; M.D.^a ; Daniel D. Sjoberg ; M.A.^b ; Melanie Bernstein ; B.A.^a ; Guido Dalbagni ; M.D.^a ; Jonathan A. Coleman ; M.D.^a ; Paul Russo ; M.D.^a
• 关键词：Nephrectomy ; Outcome prediction ; Renal cell carcinoma ; Surgical treatment delay
• 刊名：Urologic Oncology: Seminars and Original Investigations
• 出版年：2016
• 出版时间：May 2016
• 年：2016
• 卷：34
• 期：5
• 页码：239.e1-239.e8
• 全文大小：310 K

d="p0005">A total of 21% of patients treated for renal tumors>4 cm had a surgical delay of>3 months.

d="p0010">Larger, symptomatic tumors were associated with a shorter surgical delay.

d="p0015">SWT was not associated with disease upstaging at the time of surgery, recurrence, or CSS, but was associated with OS.

d="p0020">Treatment of comorbidities was a common cause for surgical delay of>3 months.